The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Frye, M. A.
* Articles by Post, R. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Frye, M. A.
* Articles by Post, R. M.
Related Collections
* Gender
* Depression
J Neuropsychiatry Clin Neurosci 11:349-353, August 1999
© 1999 American Psychiatric Press, Inc.

CSF Thyrotropin-Releasing Hormone Gender Difference

Implications for Neurobiology and Treatment of Depression

Mark A. Frye, M.D., Keith A. Gary, Ph.D., Lauren B. Marangell, M.D., Mark S. George, M.D., Ann M. Callahan, M.D., John T. Little, M.D., Teresa Huggins, Ph.D., Gabriela Corá-Locatelli, M.D., Elizabeth A. Osuch, M.D., Andrew Winokur, M.D., Ph.D. and Robert M. Post, M.D.

Received June 4, 1998; revised August 27, 1998; accepted October 29, 1998. From the Biological Psychiatry Branch, National Institute of Mental Health (NIMH), Bethesda, Maryland; UCLA School of Medicine, Los Angeles, California; University of Connecticut Health Center, Farmington, Connecticut; Baylor School of Medicine, Houston, Texas; Medical University of South Carolina, Charleston, South Carolina; Brown University School of Medicine, Providence VA Medical Center, Providence, Rhode Island; Western Psychiatric Institute, University of Pittsburgh, Pittsburgh, Pennsylvania; and Laboratory of Clinical Science, NIMH, Bethesda, Maryland. Address correspondence to Dr. Frye, 300 UCLA Medical Plaza, Suite 2341, Los Angeles, CA 90095.

In light of the postulated role of thyrotropin-releasing hormone (TRH) as an endogenous antidepressant, 56 refractory mood-disordered patients and 34 healthy adult control subjects underwent lumbar puncture for cerebrospinal fluid (CSF) TRH analysis. By two-way analysis of variance, there was no difference between CSF TRH in patients (as a group or by diagnostic subtype) and control subjects (n=90, F=0.91, df= 2,84, P=0.41). There was, however, a CSF TRH gender difference (females, 2.95 pg/ml; males, 3.98 pg/ml; n=90, F=4.11, df= 1,84, P<0.05). A post hoc t-test revealed the greatest gender difference in the bipolar group (t=2.52, P<0.02). There was no significant difference in CSF TRH in "ill" vs. "well" state (n=20, P=0.41). The role of elevated levels of CSF TRH in affectively ill men—or the role of decreased levels of CSF TRH in affectively ill women—remains to be investigated but could be of pathophysiological relevance.

Key Words: Thyrotropin-Releasing Hormone • Depression • Gender







Get information about faster international access.

Privacy Policy

Copyright © 1999 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org